Post Time: 2025-02-18
Error: No content files found.Novo Nordisk is facing the prospect of intensifying competition in the Chinese Recommended Studying market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment linked site Wegovy, clinical trial records showed. #novonordisk #wegovyweightloss #wgovy #ozempicweightloss #ozempic #china #drugmakers #News #Reuters #Newsfeed Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on Twitter: Going to Follow Reuters on Instagram: